Myelodysplastic Syndrome 2 Test, Price, Normal Range | Sprint Diagnostics Hyderabad
Patient Preparing : No special preparation is required for this test.
Myelodysplastic Syndrome (MDS) refers to a group of disorders that affect the bone marrow's ability to produce healthy blood cells. MDS-2 is a specialized diagnostic test using Fluorescence In Situ Hybridization (FISH) to detect multiple chromosomal abnormalities, including trisomy 8, del7q, del5q, del20q, Monosomy 7, and Monosomy 5, which are associated with MDS.
Myelodysplastic Syndrome encompasses a variety of disorders characterized by the bone marrow's inability to effectively produce blood cells. This can lead to a range of symptoms, including anemia, infections, and bleeding. Chromosomal abnormalities play a significant role in the development and progression of MDS.
Fluorescence In Situ Hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes to detect specific chromosomal abnormalities. The MDS-2 test exclusively uses FISH to detect trisomy 8, del7q, del5q, del20q, Monosomy 7, and Monosomy 5, which are chromosomal abnormalities commonly associated with MDS.
|Myelodysplastic Syndrome (MDS) -2: FISH for Multiple Chromosomal Abnormalities
|No special preparation is required for this test.
|Price in Hyderabad
What is the MDS-2 test?
The MDS-2 test is a genetic test that uses Fluorescence In Situ Hybridization (FISH) to detect specific chromosomal abnormalities commonly associated with Myelodysplastic Syndrome (MDS), including trisomy 8, del7q, del5q, del20q, Monosomy 7, and Monosomy 5.
Why is the MDS-2 test important?
The MDS-2 test is essential in the diagnosis and management of MDS. The presence of specific chromosomal abnormalities can provide information regarding the severity of the disease and can influence treatment decisions.
Home Sample Collection
How is the MDS-2 test performed?
Blood or bone marrow is collected from the patient. In the laboratory, the sample is treated with fluorescent probes that bind to specific chromosomal regions. These regions are then viewed under a fluorescence microscope to detect any chromosomal abnormalities.
What do the results of the MDS-2 test mean?
The results of the MDS-2 test indicate whether or not specific chromosomal abnormalities associated with MDS are present. The presence of these abnormalities can suggest a diagnosis of MDS and give insight into the severity and prognosis of the disease.
Is there any preparation required before undergoing the MDS-2 test?
No special preparation is needed for the MDS-2 test. However, it’s essential to inform your doctor about any medications or supplements you are taking.
Which doctor should I consult if the test results are abnormal?
If the results of your MDS-2 test are abnormal, you should consult a hematologist or oncologist experienced in the management of blood disorders.
How reliable is the MDS-2 test?
The MDS-2 test is highly reliable for detecting the specific chromosomal abnormalities it is designed to identify. However, interpreting the results and their clinical significance should be done by a specialist.
Can the MDS-2 test be done during treatment for MDS?
Yes, the MDS-2 test can be performed during treatment to monitor the response to therapy and assess disease progression.
Are there any risks associated with the MDS-2 test?
The risks associated with the MDS-2 test are minimal and primarily relate to the blood or bone marrow sample collection, which may cause slight pain or bruising.
What is the difference between MDS-1 and MDS-2 tests?
While both tests are designed to detect chromosomal abnormalities associated with MDS, the MDS-1 test uses both Karyotyping and FISH, whereas MDS-2 exclusively utilizes FISH.
Can MDS-2 detect all cases of MDS?
No, MDS-2 is designed to detect specific chromosomal abnormalities and may not identify all cases of MDS.
What is the difference between deletion (del) and monosomy?
Deletion refers to the loss of a portion of a chromosome, whereas monosomy is the complete loss of an entire chromosome.
What is trisomy 8?
Trisomy 8 refers to the presence of an extra copy of chromosome 8. It is a chromosomal abnormality associated with various forms of MDS.
How can the MDS-2 test affect treatment decisions?
The results of the MDS-2 test can influence treatment decisions by providing information on the genetic basis of the disease. Certain chromosomal abnormalities may indicate a need for more aggressive therapy.
What are the next steps if chromosomal abnormalities are detected?
If chromosomal abnormalities are detected, your doctor will discuss the results with you and suggest a tailored treatment plan, which may include chemotherapy, blood transfusions, or stem cell transplantation.
Myelodysplastic Syndrome (MDS) is a complex group of bone marrow disorders characterized by ineffective blood cell production. The MDS-2 test, through the use of FISH, plays a vital role in the identification of chromosomal abnormalities associated with MDS. This information is crucial in diagnosing the condition, understanding its severity, and formulating a personalized treatment plan. If you are experiencing symptoms of MDS or have been diagnosed with it, speak to your doctor about the benefits of undergoing the MDS-2 test. This test can be an invaluable tool in optimizing the management of MDS and improving patient outcomes.
Book Your Slot
Our Locations Near You in Hyderabad
3KM from Banjara Hills
1.9KM from Yusufguda
3KM from Madhura Nagar
5KM from Shaikpet